annual Report 2009 - STRATEC Biomedical AG

The net result on financial instruments broken down into the respective measurement categories was as follows:
From subsequent measurement
in v thousand
2009
(2008)
From
interest and
dividends
Fair value
Currency
translation
Impairment
From
disposals
Net result
2009
(2008)
Cash and cash
equivalents 108
(634)
0
(0)
57
(-189)
0
(0)
0
(0)
165
(445)
Loans and receivables 4
(7)
0
(0)
-22
(7)
57
(16)
-32
(0)
7
(30)
Financial assets
available for sale 0
(0)
0
(-2,075)
0
(0)
0
(0)
188
(0)
188
(-2,075)
Financial assets held for trading 0
(8)
361
(-131)
0
(0)
0
(0)
0
(0)
361
(-123)
Financial liabilities held for trading 0
(-52)
0
(0)
0
(0)
0
(0)
0
(63)
0
(11)
Financial liabilities measured
at (amortized cost) -214
(-224)
0
(0)
-3
(16)
0
(0)
29
(183)
-188
(-25)
Total -102
(-358)
361
(-2,206)
32
(-173)
57
(16)
185
(246)
533
(-1,767)
Interest expenses and interest income resulting from financial instruments measured at amortized cost are recognized
under net financial expenses. The net result on financial instruments measured at fair value is recognized under other
financial income/expenses. Information about the individual components of net financial expenses can be found in
Section V “Disclosures relating to the statement of comprehensive income / (26) Net financial expenses”.
The gains and losses resulting from translation through profit or loss of financial assets and liabilities at average exchange
rates on the balance sheet date are recognized under other operating income or expenses, as are the results of foreign
currency translation performed during the financial year. The translation of cash and cash equivalents at the balance
sheet date resulted in currency income of u 57 thousand recognized through profit or loss under other operating income
(previous year: other operating expenses in connection with currency expenses: u 189 thousand).
Hierarchical classification of financial assets and liabilities measured at fair value
To account for the relevance of the factors included in the measurement of financial assets and liabilities measured at
fair value, these financial assets and liabilities have been classified into three hierarchical levels. The levels in the fair
value hierarchy and their application to assets and liabilities are described below:
Level 1:
Level 2:
Level 3:
Listed prices for identical assets and liabilities in active markets (used without amendment)
Input factors not involving Level 1 listed prices, but which can be observed for the relevant asset or liability either
directly (that is as a price) or indirectly (that is derived from prices)
Factors used in the measurement of assets or liabilities which are not based on observable market data
(non-observable input factors).
At STRATEC AG, only securities have still been measured at fair value as of the balance sheet date. These are classified
to Level 1 of the fair value hierarchy.
102 stratec Annual Report 2009